Nu Skin in freefall after revenue guidance chopped
Feb 12 2016, 08:42 ET | | By: Clark Schultz, SA News Editor
*Shares of Nu Skin (NYSE:NUS) are down sharply in early trading after Q4 results came up short.
*Sales in Greater China fell 8% to $195.5M (-5% constant currency), North Asia sales were down 7%.
*The real crusher: The company lowered 2016 revenue guidance to $2.10B-$2.15B vs. $2.29B-$2.33B and $2.32B consensus.
* NUS -23.19% premarket to $23.95.
* Nu Skin (NYSE:NUS): Q4 EPS of $0.62 misses by $0.11.
* Revenue of $572.2M (-6.1% Y/Y) misses by $13.72M.
* Shares -15.38%.
Sucks to be peddling over-priced, useless products doesn't it?Women start economizing - they go to the commercial store brands - Neutrogena, Olay, etc, or to on-line health stores for same ingredients at 1/3 of price. China's economy taking a slash, US getting cautious, Japan in negative territory, and India women make mostly make their own products - so the women of the household start economizing on a personal level.